Garunkstiene Rasa, Levuliene Ruta, Cekuolis Andrius, Cerkauskiene Rimante, Drazdiene Nijole, Liubsys Arunas
Neonatology Centre, Vilnius University Hospital Santaros Klinikos, LT-08406 Vilnius, Lithuania.
Neonatal Department, Obstetrics and Gynecology Clinic, Vilnius City Clinical Hospital, LT-10207 Vilnius, Lithuania.
Medicina (Kaunas). 2024 Nov 21;60(12):1910. doi: 10.3390/medicina60121910.
: Nephrocalcinosis (NC) is a common condition characterized by the deposition of calcium salts in the kidneys of very preterm infants due to tubular immaturity, intensive treatment and nutritional supplements. However, optimal vitamin D supplementation remains unclear. In most patients, NC spontaneously resolves within the first year of life, but long-term kidney function data are lacking. The aim was to study nephrocalcinosis in very preterm infants, assess risk factors and evaluate vitamin D's impact during the first month with a 2-year follow-up. : This was a prospective observational study conducted over a 3-year period in infants with a gestational age of less than 32 weeks. The patients' data were compared between the NC and control groups based on kidney ultrasound results at discharge. In the first month, the mean vitamin D intake from all sources as well as biochemical markers of calcium metabolism were collected. Patients diagnosed with NC were referred to a pediatric nephrologist after discharge. : NC was found in 35% of a cohort of 160 infants, more common in those with a gestational age <28 weeks. Risk factors were associated with higher morbidity and necessary treatment. At 28 days, serum 25-hydroxy vitamin D levels differed between NC and control groups ( < 0.05). The NC group with GA ≥ 28 weeks had higher vitamin D intake ( < 0.05), hypercalciuria and calcium/creatinine ratio ( < 0.01) and lower parathyroid hormone levels ( < 0.05). Follow-up showed resolution in 70% at 12 months and 90% at 24 months. : The prevalence of NC in very preterm infants is significant, associated with lower maturity and higher morbidity. Careful vitamin D supplementation and biochemical monitoring of Ca metabolism from the first month of life should support bone health and limit the risk of nephrocalcinosis. Due to the high incidence of NC in very preterm infants, long-term follow-up is essential.
肾钙质沉着症(NC)是一种常见病症,其特征是由于肾小管不成熟、强化治疗和营养补充剂,导致极早产儿的肾脏中钙盐沉积。然而,最佳维生素D补充方案仍不明确。在大多数患者中,NC在出生后第一年内会自行消退,但缺乏长期肾功能数据。本研究旨在对极早产儿的肾钙质沉着症进行研究,评估危险因素,并在2年随访期间评估维生素D在出生后第一个月的影响。
这是一项为期3年的前瞻性观察性研究,研究对象为孕周小于32周的婴儿。根据出院时的肾脏超声结果,对NC组和对照组的患者数据进行比较。在出生后的第一个月,收集所有来源的平均维生素D摄入量以及钙代谢的生化指标。确诊为NC的患者出院后转诊至儿科肾病专家处。
在160名婴儿队列中,35%被发现患有NC,在孕周<28周的婴儿中更为常见。危险因素与更高的发病率和必要的治疗相关。在出生后28天,NC组和对照组的血清25-羟维生素D水平存在差异(P<0.05)。孕周≥28周的NC组维生素D摄入量更高(P<0.05)、高钙尿症和钙/肌酐比值更高(P<0.01),甲状旁腺激素水平更低(P<0.05)。随访显示,12个月时70%的患者病情缓解,24个月时90%的患者病情缓解。
极早产儿中NC的患病率较高,与较低的成熟度和较高的发病率相关。从出生后第一个月开始仔细补充维生素D并对钙代谢进行生化监测,应有助于骨骼健康并降低肾钙质沉着症的风险。由于极早产儿中NC的发病率较高,长期随访至关重要。